Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2020 Financial Results


SOUTH PLAINFIELD, N.J., Oct. 15, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2020 financial results and provide an update on the company's business and outlook on Thursday, October 29, 2020 at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 7096445. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:

Media:

Investors:

Jane Baj

Lisa Hayes

+1 (908) 912-9167

+1 (732) 354-8687

[email protected]

[email protected]  

 

SOURCE PTC Therapeutics, Inc.


These press releases may also interest you

at 12:16
Amae Health, Innovative Treatment Provider for Severe Mental Illness, Announces Closing of Oversubscribed $15 Million Series A Funding Round
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:05
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadranttm for Supply Chain Planning Solutions
Kinaxis® Inc. , a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadranttm for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis...

at 12:05
Radiance Biopharma to Present at LSX World Congress 2024
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

at 12:00
Jill Priya Keshyap Tapped as Guild of Guardians Executive Producer, Bringing Experience from Animoca Brands, Voodoo.io, Facebook, and more
Today, Immutable Games, a global leader in web3 game development and publishing, announced the hiring of Priya Keshyap as Executive Producer for Guild of Guardians, the epic fantasy RPG which comes to mobile on May 15. Keshyap draws on more than a...

at 11:53
Emmy-winning Cyberchase Expands Digital Presence to Engage Every Kid, Everywhere Ahead of Season 15 Premiere
Cyberchase, The WNET Group's multiple Emmy-winning math and environmental literacy series for kids ages 6-8, launches its 15th season with an unprecedented digital offering to meet young viewers where they are. An expansive slate of programming...

at 11:50
Testing Novel 3D Mapping Technology to Transform Space Exploration and Benefit Industries on Earth
When you go on a trip, you might reach for a map to help navigate your journey or pull up GPS on your phone. But what if the destination is on another planet, and there is no map? A new project sponsored by the International Space Station (ISS)...

More news about Science and technology...


News published on and distributed by: